JP2007500181A5 - - Google Patents

Download PDF

Info

Publication number
JP2007500181A5
JP2007500181A5 JP2006521672A JP2006521672A JP2007500181A5 JP 2007500181 A5 JP2007500181 A5 JP 2007500181A5 JP 2006521672 A JP2006521672 A JP 2006521672A JP 2006521672 A JP2006521672 A JP 2006521672A JP 2007500181 A5 JP2007500181 A5 JP 2007500181A5
Authority
JP
Japan
Prior art keywords
weight
part foam
delivery system
drug delivery
water
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006521672A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007500181A (ja
JP4953815B2 (ja
Filing date
Publication date
Priority claimed from GBGB0317869.6A external-priority patent/GB0317869D0/en
Application filed filed Critical
Publication of JP2007500181A publication Critical patent/JP2007500181A/ja
Publication of JP2007500181A5 publication Critical patent/JP2007500181A5/ja
Application granted granted Critical
Publication of JP4953815B2 publication Critical patent/JP4953815B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2006521672A 2003-07-30 2004-07-30 改良された薬物送達システム Expired - Fee Related JP4953815B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0317869.6A GB0317869D0 (en) 2003-07-30 2003-07-30 Improved drug delivery system
GB0317869.6 2003-07-30
PCT/GB2004/003329 WO2005011628A2 (en) 2003-07-30 2004-07-30 Oral delivery system comprising a biliquid foam

Publications (3)

Publication Number Publication Date
JP2007500181A JP2007500181A (ja) 2007-01-11
JP2007500181A5 true JP2007500181A5 (enExample) 2007-09-13
JP4953815B2 JP4953815B2 (ja) 2012-06-13

Family

ID=27799499

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006521672A Expired - Fee Related JP4953815B2 (ja) 2003-07-30 2004-07-30 改良された薬物送達システム

Country Status (14)

Country Link
US (1) US20060228408A1 (enExample)
EP (1) EP1653923B1 (enExample)
JP (1) JP4953815B2 (enExample)
CN (2) CN1832727A (enExample)
AT (1) ATE465715T1 (enExample)
AU (1) AU2004261053B2 (enExample)
CA (1) CA2533833C (enExample)
DE (1) DE602004026879D1 (enExample)
DK (1) DK1653923T3 (enExample)
ES (1) ES2344898T3 (enExample)
GB (1) GB0317869D0 (enExample)
RU (1) RU2353350C2 (enExample)
WO (1) WO2005011628A2 (enExample)
ZA (1) ZA200600761B (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0404403D0 (en) * 2004-02-27 2004-03-31 Disperse Ltd Dispersions
US10265265B2 (en) 2007-03-15 2019-04-23 Drug Delivery Solutions Limited Topical composition
GB0712389D0 (en) * 2007-06-26 2007-08-01 Drug Delivery Solutions Ltd A Pharmaceutical composition
EP2008651A1 (en) 2007-06-26 2008-12-31 Drug Delivery Solutions Limited A bioerodible patch
CN101780037B (zh) * 2010-02-03 2011-11-16 南昌大学 双嘧达莫自乳化给药系统及其制备方法
GB201006218D0 (en) 2010-04-14 2010-06-02 Ayanda As Composition
ES2736256T3 (es) 2011-03-14 2019-12-27 Drug Delivery Solutions Ltd Composición oftálmica
EP3178470A1 (en) * 2011-04-11 2017-06-14 Vitux Group AS Oral pharmaceutical dispersion compositions
EP3542788A1 (en) 2018-03-19 2019-09-25 MC2 Therapeutics Limited Topical composition comprising calcipotriol and betamethasone dipropionate

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4486333A (en) * 1981-04-10 1984-12-04 Felix Sebba Preparation of biliquid foam compositions
US4999198A (en) * 1989-03-23 1991-03-12 The Board Of Governors For Higher Education, State Of Rhode Island And Providence Plantations Polyaphrons as a drug delivery system
IL105553A (en) * 1992-05-06 1998-01-04 Janssen Pharmaceutica Inc Solid dosage form comprising a porous network of matrix forming material which disperses rapidly in water
US5840881A (en) * 1992-11-27 1998-11-24 Takeda Chemical Industries, Ltd. Composition containing a water-insoluble or slightly water-soluble compound with enhanced water-solubility
AU721918B2 (en) * 1996-03-08 2000-07-20 Disperse Limited Dispersion comprising an oil-based biliquid foam and an aqueous gel
NL1003503C2 (nl) * 1996-07-04 1998-01-07 Negma Steba International Dev Farmaceutische samenstelling voor orale toediening.
GB2326337A (en) * 1997-06-20 1998-12-23 Phares Pharma Holland Homogeneous lipid compositions for drug delivery
CN1362873A (zh) * 2000-02-22 2002-08-07 彩色通路公司 胶凝的水溶液美容组合物
GB0214793D0 (en) * 2002-06-26 2002-08-07 Disperse Technologies Plc Biliquid foam entrapment

Similar Documents

Publication Publication Date Title
EP1781257A4 (en) PHARMACEUTICAL FORMULATIONS WITH MICROPARTICLES OR NANOPARTICLES OF AN AGENT
JP2008513467A5 (enExample)
JP2006517944A5 (enExample)
JP2009280627A5 (enExample)
TW200613004A (en) External preparation of solid/oil type
RU2350333C3 (ru) Применение ивермектина для лечения дерматологических расстройств
JP2007511516A5 (enExample)
JP2004515500A5 (enExample)
JP2004529078A5 (enExample)
JP2004523498A5 (enExample)
JP2004532810A5 (enExample)
EA200600484A1 (ru) Доставка физиологических агентов in situ при помощи гелей, включающих анионные полисахариды
JP2007500181A5 (enExample)
MX2008011823A (es) Forma de dosificacion solida que contiene un agente activo de sabor encubierto.
JP2009538268A5 (enExample)
ATE493973T1 (de) Irbesartan enthaltende pharmazeutische zusammensetzung
JP2010518086A5 (enExample)
JP2008531742A5 (enExample)
JP2007501248A5 (enExample)
JP2006514100A5 (enExample)
TW200502008A (en) Patches for mucosa of oral cavity containing fentanyl
JP2013505233A5 (enExample)
JP2018039810A5 (enExample)
DK1653923T3 (da) Oral afleveringssystem omfattende en bivæsket skum
JP2002537232A5 (enExample)